These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31281384)

  • 1. Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Sobuś A; Wełnicka A; Meller A; Machowska-Sempruch K; Zawiślak A; Łuczkowska K; Milczarek S; Osękowska B; Paczkowska E; Rotter I; Nowacki P; Machaliński B
    Stem Cells Int; 2019; 2019():7213854. PubMed ID: 31281384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Pius-Sadowska E; Litwińska Z; Kotowski M; Meller A; Rotter I; Peregud-Pogorzelski J; Nowacki P
    Int J Med Sci; 2020; 17(13):1927-1935. PubMed ID: 32788871
    [No Abstract]   [Full Text] [Related]  

  • 3. Humoral Influence of Repeated Lineage-Negative Stem/Progenitor Cell Administration on Articulatory Functions in ALS Patients.
    Sobuś A; Baumert B; Pawlukowska W; Gołąb-Janowska M; Paczkowska E; Wełnicka A; Meller A; Machowska-Sempruch K; Zawiślak A; Łuczkowska K; Milczarek S; Osękowska B; Safranow K; Rotter I; Nowacki P; Machaliński B
    Stem Cells Int; 2020; 2020():8888271. PubMed ID: 33381192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles.
    Sobuś A; Baumert B; Litwińska Z; Gołąb-Janowska M; Stępniewski J; Kotowski M; Pius-Sadowska E; Kawa MP; Gródecka-Szwajkiewicz D; Peregud-Pogorzelski J; Dulak J; Nowacki P; Machaliński B
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Meller A; Machowska-Sempruch K; Wełnicka A; Paczkowska E; Rotter I; Machaliński B; Nowacki P
    BMC Neurol; 2019 Oct; 19(1):241. PubMed ID: 31629403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients.
    Baumert B; Sobuś A; Gołąb-Janowska M; Ulańczyk Z; Paczkowska E; Łuczkowska K; Zawiślak A; Milczarek S; Osękowska B; Meller A; Machowska-Sempruch K; Wełnicka A; Safranow K; Nowacki P; Machaliński B
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction.
    Baumert B; Przybycień K; Paczkowska E; Kotowski M; Pius-Sadowska E; Safranow K; Peregud-Pogorzelski J; Kornacewicz-Jach Z; Peregud-Pogorzelska M; Machaliński B
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction.
    Peregud-Pogorzelska M; Przybycień K; Baumert B; Kotowski M; Pius-Sadowska E; Safranow K; Peregud-Pogorzelski J; Kornacewicz-Jach Z; Paczkowska E; Machaliński B
    Int J Med Sci; 2020; 17(8):985-994. PubMed ID: 32410827
    [No Abstract]   [Full Text] [Related]  

  • 9. Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells-Focus on Immunological Pathways in Patients with ALS.
    Baumert B; Sobuś A; Gołąb-Janowska M; Paczkowska E; Łuczkowska K; Rogińska D; Zawiślak A; Milczarek S; Osękowska B; Pawlukowska W; Meller A; Machowska-Sempruch K; Wełnicka A; Safranow K; Nowacki P; Machaliński B
    Cells; 2020 Aug; 9(8):. PubMed ID: 32752182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients.
    Sobuś A; Baumert B; Gołąb-Janowska M; Kulig P; Paczkowska E; Łuczkowska K; Rogińska D; Zawiślak A; Milczarek S; Osękowska B; Pawlukowska W; Meller A; Machowska-Sempruch K; Wełnicka A; Nowacki P; Machaliński B
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship between Selected Demographic Factors and Speech Organ Dysfunction in Sporadic ALS Patients.
    Pawlukowska W; Baumert B; Gołąb-Janowska M; Meller A; Machowska-Sempruch K; Wełnicka A; Paczkowska E; Rotter I; Machaliński B; Nowacki P
    Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32764342
    [No Abstract]   [Full Text] [Related]  

  • 12. G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).
    Salamone P; Fuda G; Casale F; Marrali G; Lunetta C; Caponnetto C; Mazzini L; La Bella V; Mandrioli J; Simone IL; Moglia C; Calvo A; Tarella C; Chio A;
    BMJ Open; 2020 Mar; 10(3):e034049. PubMed ID: 32209625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.
    Prabhakar S; Marwaha N; Lal V; Sharma RR; Rajan R; Khandelwal N
    Neurol India; 2012; 60(5):465-9. PubMed ID: 23135021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
    Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
    Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
    Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
    Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro.
    Zhang Y; Harada A; Bluethmann H; Wang JB; Nakao S; Mukaida N; Matsushima K
    Blood; 1995 Oct; 86(8):2930-7. PubMed ID: 7579385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatiotemporal Control of Articulation During Speech and Speechlike Tasks in Amyotrophic Lateral Sclerosis.
    Rong P; Heidrick L
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1382-1399. PubMed ID: 33630657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Articulatory Range of Movement in Individuals With Dysarthria Secondary to Amyotrophic Lateral Sclerosis.
    Lee J; Bell M
    Am J Speech Lang Pathol; 2018 Aug; 27(3):996-1009. PubMed ID: 29800071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients.
    Deepa P; Shahani N; Alladi PA; Vijayalakshmi K; Sathyaprabha TN; Nalini A; Ravi V; Raju TR
    J Neural Transm (Vienna); 2011 Apr; 118(4):531-8. PubMed ID: 21069391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral activity of cord blood-derived stem/progenitor cells: implications for stem cell-based adjuvant therapy of neurodegenerative disorders.
    Paczkowska E; Kaczyńska K; Pius-Sadowska E; Rogińska D; Kawa M; Ustianowski P; Safranow K; Celewicz Z; Machaliński B
    PLoS One; 2013; 8(12):e83833. PubMed ID: 24391835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.